Browse Drug Recalls
1,317 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,317 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,317 FDA drug recalls in IL.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jun 21, 2012 | Lactated Ringer's Injection, USP, 1000 mL, Rx only, Manufactured by Hospira, ... | CGMP Deviations: Shipment of product not approved for release. | Class III | Hospira, Inc. |
| May 14, 2012 | Zemplar (paricalcitol) Injection, 5 mcg/mL in 2 mL multi-dose vials, 25 vial ... | CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have app... | Class II | Abbott Laboratories |
| May 12, 2012 | HYDROmorphone HCl Injection, USP, 1 mg/mL, 1 mL fill in a 2.5 mL Carpuject pr... | Superpotent (Single Ingredient) Drug: Some of the prefilled cartridge units have been found to be... | Class I | Hospira Inc. |
| May 8, 2012 | Morton, Sodium Chloride, USP, Granular, packaged in kraft paper bags, fiber d... | Impurities/Degradation Products: The product was found to contain a slightly out of specification... | Class III | Morton Salt Co. |
| May 4, 2012 | 1.5% Glycine Irrigation, USP, 3000 mL, Rx Only, Hospira, Inc., Lake Forest, I... | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possibl... | Class II | Hospira Inc. |
| May 4, 2012 | 5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL VisIV Container... | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possibl... | Class II | Hospira Inc. |
| May 4, 2012 | 0.45% Sodium Chloride Injection, USP, Rx Only, 250 mL, by Hospira, Inc., Lake... | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possibl... | Class II | Hospira Inc. |
| May 4, 2012 | 70% Dextrose Injection USP, 2000 mL, Rx Only, by Hospira, Inc., Lake Forest, ... | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possibl... | Class II | Hospira Inc. |
| May 4, 2012 | 0.9% Sodium Chloride Injection, USP, Polyolefin Flexible Container, a) 500 mL... | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possibl... | Class II | Hospira Inc. |
| May 4, 2012 | 20% Dextrose Injection, USP, a) 500 mL in 1000 mL Partial-Fill Container (NDC... | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possibl... | Class II | Hospira Inc. |
| May 4, 2012 | 5% Dextrose Injection USP, a) 250 mL (NDC 0409-7922-02), b) 500 mL (NDC 0409-... | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possibl... | Class II | Hospira Inc. |
| May 4, 2012 | 0.9% Sodium Chloride Injection, USP, a) 50 mL (NDC 0409-7984-13), b) 50 mL (N... | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possibl... | Class II | Hospira Inc. |
| May 4, 2012 | 0.9% Sodium Chloride Irrigation, USP, 3000 mL, Rx Only, Hospira, Inc., Lake F... | Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possibl... | Class II | Hospira Inc. |
| Apr 17, 2012 | Morphine Sulfate Injection, USP, 4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartr... | Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL | Class I | Hospira Inc. |
| Apr 11, 2012 | Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 U... | Presence of Particulate Matter: A single visible particulate was observed in a retention sample b... | Class II | Hospira, Inc. |
| Apr 5, 2012 | Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g t... | Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesi... | Class III | Hospira, Inc. |
| Mar 9, 2012 | Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufact... | Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is... | Class III | Pack Pharmaceuticals |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.